Active ingredients: lamotrigine
What it is used for
Torlemo dispersible tablets are indicated for the treatment of: Partial and generalised seizures in adults and children. There is extensive experience with Torlemo use initially as add-on therapy. Torlemo has also been found to be effective as monotherapy following withdrawal of concomitant antiepileptic drugs. Initial monotherapy in newly diagnosed paediatric patients is not recommended. (see Actions, Clinical trials.)
How to take it
The way to take this medicine is: Oral. This medicine is taken by mouth.
- Store below 25 degrees Celsius
- Protect from Light
- Protect from Moisture
- Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
White to off white, round, flat faced beveled edge tablets, plain on both sides.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient lamotrigine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems